I 
2,555
+1.59%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩5.74bn
FY2016FY2025
Net income
−₩8.96bn
FY2016FY2025
Free cash flow
−₩7.68bn
FY2016FY2025
Shareholders' equity
₩69.87bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩5.74bn | ₩6.42bn | ₩9.59bn | ₩14.01bn | ₩29.31bn | ₩45.43bn | ₩8.35bn | ₩20.58bn | ₩10.96bn | ₩10.22bn |
| Research and development | ₩4.65bn | ₩3.48bn | ₩3.17bn | ₩3.31bn | ₩3.55bn | ₩3.49bn | ₩2.25bn | ₩3.66bn | ₩3.50bn | ₩3.11bn |
| Operating income | −₩7.90bn | −₩5.24bn | −₩9.04bn | −₩1.47bn | ₩10.08bn | ₩15.87bn | −₩4.25bn | ₩5.17bn | −₩6.37bn | −₩1.17bn |
| Net income | −₩8.96bn | −₩2.59bn | −₩9.70bn | ₩5.71bn | ₩9.73bn | ₩14.95bn | −₩3.19bn | ₩8.71bn | −₩8.73bn | −₩610.4m |
| Diluted earnings per share | -299.17 | -86.53 | -323.78 | 190.75 | 324.87 | 499.19 | -106.44 | 286.49 | -283.72 | -20.38 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩74.32bn | ₩86.37bn | ₩98.61bn | ₩140.96bn | ₩153.37bn | ₩100.54bn | ₩89.03bn | ₩54.80bn | ₩45.63bn | ₩59.61bn |
| Cash and short-term investments | — | — | ₩57.18bn | ₩47.35bn | ₩83.50bn | ₩66.17bn | ₩69.57bn | ₩33.11bn | ₩23.98bn | ₩28.34bn |
| Total liabilities | ₩4.45bn | ₩2.60bn | ₩1.88bn | ₩34.78bn | ₩52.02bn | ₩15.16bn | ₩24.07bn | ₩15.70bn | ₩15.38bn | ₩10.46bn |
| Debt | — | ₩861.4m | ₩258.3m | ₩286.4m | ₩16.13bn | ₩174.3m | ₩14.77bn | ₩3.22bn | ₩3.55bn | ₩2.55bn |
| Shareholders' equity | ₩69.87bn | ₩83.77bn | ₩96.73bn | ₩106.18bn | ₩101.35bn | ₩85.38bn | ₩64.96bn | ₩39.09bn | ₩30.24bn | ₩49.15bn |
| Shares outstanding | 30m | 30m | 30m | 30m | 30m | 30m | 30m | 30m | 31m | 30m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩5.21bn | −₩138.5m | ₩3.12bn | ₩5.98bn | ₩16.47bn | ₩7.13bn | −₩812.5m | ₩4.20bn | −₩5.47bn | −₩4.64bn |
| Capital spending | −₩2.47bn | −₩1.19bn | −₩9.55bn | −₩2.23bn | −₩3.05bn | −₩4.85bn | −₩300.4m | −₩550.6m | −₩973.9m | −₩4.72bn |
| Free cash flow | −₩7.68bn | −₩1.32bn | −₩6.43bn | ₩3.75bn | ₩13.43bn | ₩2.28bn | −₩1.11bn | ₩3.65bn | −₩6.44bn | −₩9.37bn |
| Dividends paid | −₩3.20bn | −₩3.32bn | — | — | — | — | — | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩2.03bn | ₩1.88bn | ₩1.70bn | ₩1.62bn | ₩1.23bn | ₩1.19bn | ₩1.52bn | ₩1.21bn |
| Operating income | −₩1.64bn | −₩2.17bn | −₩2.04bn | −₩2.07bn | −₩1.96bn | −₩1.71bn | −₩1.34bn | −₩1.63bn |
| Net income | −₩2.26bn | −₩2.26bn | −₩4.15bn | −₩1.67bn | −₩1.11bn | −₩2.03bn | −₩1.48bn | −₩1.32bn |
| Diluted earnings per share | -75.44 | -75.59 | -138.49 | -55.63 | -37.13 | -67.92 | -49.37 | -43.96 |
| Cash from operations | −₩581.0m | −₩2.12bn | −₩1.58bn | −₩993.0m | −₩4.58bn | ₩1.94bn | −₩138.0m | −₩19.0m |
| Capital spending | −₩106.0m | −₩61.0m | −₩1.38bn | — | −₩778.0m | −₩321.0m | −₩1.19bn | −₩147.0m |
| Free cash flow | −₩687.0m | −₩2.18bn | −₩2.96bn | — | −₩5.36bn | ₩1.62bn | −₩1.32bn | −₩166.0m |
| Total assets | ₩68.37bn | ₩70.68bn | ₩74.32bn | ₩78.70bn | ₩81.67bn | ₩82.62bn | ₩86.37bn | ₩90.97bn |
| Cash and short-term investments | — | — | — | — | — | — | — | ₩54.38bn |
| Debt | ₩1.80bn | ₩1.80bn | — | — | — | — | ₩861.4m | ₩252.6m |
| Shareholders' equity | ₩62.17bn | ₩64.43bn | ₩69.87bn | ₩73.98bn | ₩75.58bn | ₩76.83bn | ₩83.77bn | ₩89.37bn |
Financial ratios
Data as of 8 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -137.7% | -81.6% | -94.3% | -10.5% | 34.4% | 34.9% | — | — | — |
| Net margin | -156.1% | -40.4% | -101.1% | 40.8% | 33.2% | 32.9% | — | — | — |
| Return on equity | -12.8% | -3.1% | -10.0% | 5.4% | 9.6% | 17.5% | — | — | — |
| Return on assets | -12.1% | -3.0% | -9.8% | 4.1% | 6.3% | 14.9% | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | -0.6% | 5.5% | -5.2% |
| Revenue growth | -10.6% | -33.0% | -31.6% | -52.2% | -35.5% | 444.3% | — | — | — |
| Earnings growth | 245.7% | -73.3% | -269.7% | -41.3% | -34.9% | -569.0% | — | — | — |
| Current ratio | 10.72x | 39.03x | 77.59x | 3.54x | 3.77x | 6.40x | — | — | — |
| Debt to equity | — | 0.01x | 0.00x | 0.00x | 0.16x | 0.00x | 0.22x | — | — |
| Equity ratio | 94.0% | 97.0% | 98.1% | 75.3% | 66.1% | 84.9% | — | — | — |
| Interest coverage | -87.89x | -223.72x | -3.10x | -0.42x | 6.16x | 13.41x | — | — | — |
| R&D as a share of sales | 81.1% | 54.2% | 33.1% | 23.6% | 12.1% | 7.7% | — | — | — |
| Buybacks as a share of market value | — | — | — | — | — | — | 1.5% | 1.2% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -25.7% | -33.9% | -7.0% |
| Operating income | 75.1% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -108.1% | -66.2% | 2.1% | -1.4% |
| Net margin | -95.0% | -43.4% | 8.3% | 4.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -10.9 | -64.8 | -27.1 | 42.6 | 64.8 | 55.8 | -145.6 | 75.2 | -78.8 | -750.6 |
| Price to sales | 16.9 | 26.2 | 27.4 | 17.4 | 21.5 | 18.4 | 55.6 | 31.8 | 62.8 | 44.8 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 27 Dec 2024.
| FY2024 | |
|---|---|
| Paid in the year | 200.00 |
- 2-for-1 split · 10 Jan 2019
- 13-for-10 split · 8 Oct 2013
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.